Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Eymin

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Letters|February 9, 2018
Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKIMarie Guerard, Thomas Robin, Pascal Perron, et al.
British Journal of Cancer|May 26, 2018
The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinomaCherine Abou Faycal, Elisabeth Brambilla, Jackeline Agorreta, et al.
Molecular Oncology|May 20, 2022
Altered splicing of ATG16-L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non-small cell lung cancerAnne-Sophie Hatat, Clara Benoit-Pilven, Amélie Pucciarelli, et al.
Nanomaterials (Basel, Switzerland)|January 15, 2021
Design of PEGylated Three Ligands Silica Nanoparticles for Multi-Receptor TargetingManon Maurel, Titouan Montheil, Julie Martin, et al.
Oncogene|September 9, 2018
VEGF<sub>165</sub>b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loopAsma Boudria, Cherine Abou Faycal, Tao Jia, et al.
Life Science Alliance|October 1, 2024
PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signalingSylvie Gazzeri, Nadiia Zubchuk, Elodie Montaudon, et al.
NAR Cancer|April 4, 2025
SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progressionManal Khalife, Tao Jia, Pierre Caron, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Letters|February 9, 2018
Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKIMarie Guerard, Thomas Robin, Pascal Perron, et al.
British Journal of Cancer|May 26, 2018
The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinomaCherine Abou Faycal, Elisabeth Brambilla, Jackeline Agorreta, et al.
Molecular Oncology|May 20, 2022
Altered splicing of ATG16-L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non-small cell lung cancerAnne-Sophie Hatat, Clara Benoit-Pilven, Amélie Pucciarelli, et al.
Nanomaterials (Basel, Switzerland)|January 15, 2021
Design of PEGylated Three Ligands Silica Nanoparticles for Multi-Receptor TargetingManon Maurel, Titouan Montheil, Julie Martin, et al.
Oncogene|September 9, 2018
VEGF<sub>165</sub>b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loopAsma Boudria, Cherine Abou Faycal, Tao Jia, et al.
Life Science Alliance|October 1, 2024
PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signalingSylvie Gazzeri, Nadiia Zubchuk, Elodie Montaudon, et al.
NAR Cancer|April 4, 2025
SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progressionManal Khalife, Tao Jia, Pierre Caron, et al.
Pageof 3